Abstract:Trianglamines, macrocyclic heteraphanes, were readily synthesised through a [3+3] cyclocondensation of (R,R)-1,2-diaminocyclohexane with terephthalaldehyde, followed by NaBH4 reduction and N-alkylation. The macrocyclic ring shows a remarkable ability to change its conformation, as a consequence of rotation about the C-N bonds or nitrogen inversion due to protonation or N-alkylation, as revealed by circular dichroism spectra, computational modelling and X-ray diffraction analysis. The flexible natures of the tr… Show more
“…This enantioselectivity is higher than that with the use of acyclic ligand 6 (ee 78%). Since trianglamine 2 can be conveniently prepared by a one-pot procedure from inexpensive tartrate salt of DACH and terephthalaldehyde, [31] the Zn complex of 2 is a good alternative to previously reported chiral catalysts.…”
Section: Discussionmentioning
confidence: 99%
“…Our previous study has shown that free ligand 2 possesses a large number of conformers belonging to families of similar structures. [31] These structures are defined by the signs and values of tor-…”
Section: Stereochemical Considerationsmentioning
confidence: 99%
“…[31] Trianglamine 2 has already been used as a chiral shift reagent for NMR spectra, [35] as a chiral probe for anion recognition in ion-trap ESI-MS [36] and as a chiral ligand for copper-catalyzed enantioselective Henry reaction. [37] Ligands 2-6 feature the same secondary 1,2-di-A C H T U N G T R E N N U N G amine structure embedded in the cyclohexane ring.…”
Section: Asymmetric Hydrosilylationmentioning
confidence: 99%
“…For the present study we have selected trianglimine 1 [30] trianglamines 2, 3, [30,31] 4, [32,33] and rhombamine 5, [34] as well as N,N'-dibenzyl-DACH (6) as a reference ligand.…”
Chiral macrocyclic tetra-and hexamine macrocycles derived from trans-1,2-diaminocyclohexane (DACH) in complexes with diethylzinc efficiently catalyze the asymmetric hydrosilylation of aryl alkyl ketones with enantiomeric excess of the product up to 89%. The cyclic structure of the trianglamine ligand increases the enantioselectivity of the reaction, in comparison to the catalysis with the acyclic N,N'-dibenzyl-DACH ligand. Density functional theory (DFT) computations on the structures of ligand-zinc complexes and on the structures of these complexes with a coordinated acetophenone molecule allow us to rationalize the direction of the asymmetric induction of the hydrosilylation reaction as well as the superiority of the cyclic ligand compared to the acyclic one. This is the first example of asymmetric catalysis for the hydrosilylation reaction of ketones with the use of a readily available, inexpensive, and reusable macrocyclic trianglamine ligand.
“…This enantioselectivity is higher than that with the use of acyclic ligand 6 (ee 78%). Since trianglamine 2 can be conveniently prepared by a one-pot procedure from inexpensive tartrate salt of DACH and terephthalaldehyde, [31] the Zn complex of 2 is a good alternative to previously reported chiral catalysts.…”
Section: Discussionmentioning
confidence: 99%
“…Our previous study has shown that free ligand 2 possesses a large number of conformers belonging to families of similar structures. [31] These structures are defined by the signs and values of tor-…”
Section: Stereochemical Considerationsmentioning
confidence: 99%
“…[31] Trianglamine 2 has already been used as a chiral shift reagent for NMR spectra, [35] as a chiral probe for anion recognition in ion-trap ESI-MS [36] and as a chiral ligand for copper-catalyzed enantioselective Henry reaction. [37] Ligands 2-6 feature the same secondary 1,2-di-A C H T U N G T R E N N U N G amine structure embedded in the cyclohexane ring.…”
Section: Asymmetric Hydrosilylationmentioning
confidence: 99%
“…For the present study we have selected trianglimine 1 [30] trianglamines 2, 3, [30,31] 4, [32,33] and rhombamine 5, [34] as well as N,N'-dibenzyl-DACH (6) as a reference ligand.…”
Chiral macrocyclic tetra-and hexamine macrocycles derived from trans-1,2-diaminocyclohexane (DACH) in complexes with diethylzinc efficiently catalyze the asymmetric hydrosilylation of aryl alkyl ketones with enantiomeric excess of the product up to 89%. The cyclic structure of the trianglamine ligand increases the enantioselectivity of the reaction, in comparison to the catalysis with the acyclic N,N'-dibenzyl-DACH ligand. Density functional theory (DFT) computations on the structures of ligand-zinc complexes and on the structures of these complexes with a coordinated acetophenone molecule allow us to rationalize the direction of the asymmetric induction of the hydrosilylation reaction as well as the superiority of the cyclic ligand compared to the acyclic one. This is the first example of asymmetric catalysis for the hydrosilylation reaction of ketones with the use of a readily available, inexpensive, and reusable macrocyclic trianglamine ligand.
“…[1][2][3][4][5][6][7] A considerable drawback of this method is the formation of by-products arising from linear polycondensation or simultaneous [n+n]-cyclocondensation of the initial α,ω-bifunctional compounds. [8][9][10][11][12][13][14] The formation of by-products is minimised, as a rule, by using high dilution, 11,15,16 templates, [17][18][19][20][21][22] and catalytic reactions. [23][24][25][26][27] Cyclophanes containing benzene rings in the molecule have rigid cyclic skeletons, which is important for their complexation of metal ions 5 and organic molecules.…”
Eine Vorliebe für β‐Glucose: Drei Dialdehyde und zwei Triamine bilden selbstorganisiert und quantitativ einen Käfigrezeptor mit Pyrroleinheiten, der unter verschiedenen Monosacchariden effizient D‐Glucopyranoside bindet und dabei ausschließlich das β‐Anomer erkennt.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.